CUTIMODULIS
LIVE

Serial Number

79423802

Owner

Beiersdorf AG

Attorney

Francis J., Duffin

Filing Date

Apr 14, 2025

Add to watchlist:

No watchlists yet
View on USPTO

CUTIMODULIS Trademark

Serial Number: 79423802 • Registration: 8290169

CUTIMODULIS is a trademark filed by Beiersdorf AG on April 14, 2025. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Beiersdorf AG (8 trademarks)

Beiersdorfstrasse 1-9

Entity Type: 99

Trademark Details

Filing Date

April 14, 2025

Registration Date

June 9, 2026

Published for Opposition

April 21, 2026

Goods & Services

Synthetic active agent in the nature of active chemical ingredients for use in the manufacture of cosmetic, dermatological or medicated preparations

Non-medicated skin care preparations.

Medicated dermatological and pharmaceutical skin care preparations.

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 9, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 9, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 21, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 21, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 15, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 24, 2026 CNSA
REFUSAL PROCESSED BY IB
Mar 19, 2026 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 13, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 13, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 13, 2026 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 28, 2026 RFCS
REFUSAL PROCESSED BY MPU
Feb 28, 2026 RFRR
NEW REPRESENTATIVE AT IB RECEIVED
Feb 12, 2026 NREP
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 1, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jan 31, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 31, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 30, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 30, 2026 NWOS
NEW REPRESENTATIVE AT IB RECEIVED
May 23, 2025 NREP
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 15, 2025 REPR